TRUVADA - emtricitabine and tenofovir disoproxil fumarate
Navigation: NDC > Supplier starting with: C > CARDINAL HEALTH| Field | Value |
|---|---|
| NDC Code: | 55154-4425 |
| Proprietary Name: | TRUVADA |
| Suffix: | |
| Non-Proprietary Name: | emtricitabine and tenofovir disoproxil fumarate |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 02-08-2004 |
| Category Name: | NDA |
| Application Number: | NDA021752 |
| Labeler: | CARDINAL HEALTH |
| Substance Name: | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
| Active Numerator Strength: | 200; 300 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| DEA Schedule: |